Wells WA, Barker PE, MacAulay C, Novelli M, Levison R, Crawford JM Validation of Novel Optical Imaging Technologies: the Pathologists’s View. J Biomed Opt. 2007 Sep-Oct;12(5):051801
Poplack SP, Tosteson TD, Wells WA, Pogue BW, Meaney PM, Hartov A, Kogel CA, Soho SK, Gibson JJ, Paulsen KD Electromagnetic Breast Imaging: Results of a pilot study in women with abnormal mammograms. Radiology 243(2):350-359, 2007
Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells WA, DiRenzo J. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Research 67(2):501-10, 2007.
Wells WA, Schwartz GN, Morganelli PM, Cole BF, Gibson JJ, Kinlaw WB Expression of “Spot 14” (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker. Breast Cancer Research and Treatment, 98(2):231-240, 2006.
Wells WA, Daghlian CP, Tosteson TD, Grove MR, Poplack SP, Soho SK, Paulsen KD Analysis of the microvasculature and tissue type ratios in benign and malignant breast tissue. Analytical and Quantitative Cytology and Histology 26:166-174, 2004.
Professional Interests:
Histomorphology quantification by image processing and analysis
Prognostic indicators and diagnostic reproducibility in breast carcinoma
Morphologic, proteomic and genetic correlates to validate novel breast imaging modalities
Grant Information:
1. IU54CA105480-01 subaward 2003-1344, PI
P.I.: Wendy A. Wells, M.B.B.S
Network for Translational Research in Optical Imaging (NTROI): Breast Cancer Multidimensional Diffuse Optical Imaging.
2. NCI P01 CA80139-0, Co-investigator
P.I.: Keith D. Paulsen, Ph.D.
Alternative Breast Cancer Imaging Modalities
3. NCI 2R01CA126618-05A2, co-investigator
P.I.: William B. Kinlaw III, M.D., PhD
The role of protein Spot 14 in normal and neoplastic mammary tissue